ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 680

$1.12M Total Retail Price of All Prescriptions

Rank: 62 out of 680

683 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

37% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 12,595 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,087 619 S3 1 4
NEXIUM 611 306 2 16
LISINOPRIL 542 368 3 5
OMEPRAZOLE 494 291 4 7
PRAVASTATIN SODIUM 389 195 5 10
GABAPENTIN 385 228 6 15
METFORMIN HCL 384 224 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 384 168 7 37
LEVOTHYROXINE SODIUM 382 241 9 2
FUROSEMIDE 374 275 10 6
TRAMADOL HCL 370 190 11 18
AZITHROMYCIN 349 218 12 42
AMLODIPINE BESYLATE 320 268 13 1
CARVEDILOL 315 190 14 23
ATENOLOL 312 215 15 19
SIMVASTATIN 306 208 16 3
POTASSIUM CHLORIDE 271 166 17 14
RANITIDINE HCL 268 173 18 56
METOPROLOL SUCCINATE 226 142 19 13
ZOLPIDEM TARTRATE 223 128 20 17
LYRICA 220 75 21 77
SERTRALINE HCL 213 158 22 28
MELOXICAM 194 104 23 24
CITALOPRAM HBR 191 109 24 22
METOPROLOL TARTRATE 178 141 25 12
TRAZODONE HCL 153 68 26 48
LOVASTATIN 150 101 27 44
ADVAIR DISKUS 147 96 28 53
PAROXETINE HCL 147 89 28 76
WARFARIN SODIUM 145 100 30 20
TAMSULOSIN HCL 143 123 31 34
GLIMEPIRIDE 136 107 32 29
GLIPIZIDE XL 136 77 32 142
DONEPEZIL HCL 135 119 34 27
METHYLPREDNISOLONE 132 84 35 93
FINASTERIDE 123 110 36 109
DIOVAN HCT 122 110 37 55
OXYBUTYNIN CHLORIDE 120 84 38 129
QUETIAPINE FUMARATE 118 50 39 64
ISOSORBIDE MONONITRATE ER 118 107 39 59
GLIPIZIDE 118 97 39 63
CLOPIDOGREL 111 77 42 26
TRIAMTERENE-HCTZ 109 62 43 52
ENALAPRIL MALEATE 108 59 44 65
HYDRALAZINE HCL 108 86 44 71
CYMBALTA 107 37 46 46
LANTUS 107 79 46 49
AMOXICILLIN 106 56 48 111
BYSTOLIC 105 47 49 79
ESCITALOPRAM OXALATE 103 72 50 45
AMITRIPTYLINE HCL 101 51 R 51 47
LOVAZA 100 60 52 119
ALLOPURINOL 100 78 52 33
CARBIDOPA-LEVODOPA 100 88 52 117
FLUOXETINE HCL 99 32 55 74
PHENYTOIN SODIUM EXTENDED 97 54 56 115
DIOVAN 96 72 57 31
GLIPIZIDE ER 95 43 58 108
HYDROXYZINE HCL 95 53 R 58 267
METHOCARBAMOL 94 40 R 60 251
HYDROCHLOROTHIAZIDE 92 54 61 9
PREDNISONE 92 60 61 50
IBUPROFEN 91 30 63 126
CYCLOBENZAPRINE HCL 90 50 R 64 81
CARISOPRODOL 89 29 R 65 83
METOCLOPRAMIDE HCL 88 69 66 118
POLYETHYLENE GLYCOL 3350 88 66 66 62
PROMETHAZINE HCL 87 41 R 68 96
ATORVASTATIN CALCIUM 87 64 68 11
NASONEX 86 58 70 197
TIZANIDINE HCL 85 40 71 140
NAMENDA 84 76 72 35
MEGESTROL ACETATE 84 70 R 72 88
CIPROFLOXACIN HCL 84 45 72 57
COMBIVENT 83 36 75 168
AMLODIPINE BESYLATE-BENAZEPRIL 82 72 76 43
MECLIZINE HCL 81 65 77 103
LOSARTAN-HYDROCHLOROTHIAZIDE 80 57 78 51
PLAVIX 78 62 79 39
SPIRONOLACTONE 76 62 80 82
PROAIR HFA 75 31 81 67
DIVALPROEX SODIUM 74 48 82 110
BUSPIRONE HCL 74 39 82 144
TRICOR 73 32 84 98
OXYCODONE HCL-ACETAMINOPHEN 73 37 S2 84 133
BENAZEPRIL HCL 73 65 84 40
PROPRANOLOL HCL 73 43 84 145
LEVOCETIRIZINE DIHYDROCHLORIDE 73 39 84 216
NIFEDIPINE ER 72 67 89 75
ALENDRONATE SODIUM 70 63 90 32
SPIRIVA 69 35 91 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 40 92 94
LACTULOSE 68 54 92 92
QUINAPRIL HCL 68 51 92 104
DOXAZOSIN MESYLATE 67 50 95 73
VOLTAREN 65 36 96 253
VERAPAMIL ER 64 23 97 100
DETROL LA 64 48 97 169
NOVOLOG 62 47 99 167
JANUVIA 61 36 100 60
TRIAMCINOLONE ACETONIDE 60 49 101 199
SUCRALFATE 59 45 102 160
PANTOPRAZOLE SODIUM 59 40 102 30
ZETIA 58 19 104 87
LIPITOR 58 46 104 68
SINGULAIR 58 42 104 91
VENTOLIN HFA 55 39 107 202
CLINDAMYCIN HCL 55 26 107 243
METRONIDAZOLE 53 28 109 306
ENDOCET 50 27 S2 110 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.